THRB (Thyroid hormone receptor beta) variants and mutations
THRB (also known as Thyroid hormone receptor beta) is a human protein-coding gene encoding a thyroid hormone receptor beta protein. Its annotated function is nuclear hormone receptor that can act as a repressor or activator of transcription. High affinity receptor for thyroid hormones, including triiodothyronine and thyroxine. It is annotated at the nucleus. This analysis covers 756 THRB variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes selective pituitary resistance to thyroid hormone, generalized resistance to thyroid hormone, and thyroid hormone resistance, generalized, autosomal dominant. Example THRB variants include T2I, T2P, and P3L.
Variant analysis overview
- Gene: THRB
- Protein: Thyroid hormone receptor beta
- UniProt accession: P10828
- Organism: Homo sapiens
- Variants analyzed: 756
- Variant scope: all variants
- Completed: 2026-09-08
Variant and mutation evidence
- Variant composition: 530 unspecified-consequence records; 141 synonymous variants; 88 missense variants; 3 in-frame deletions; 2 stop-gained variants; 6 frameshift variants; 4 splice-region variants
- Prediction scores: 593 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: selective pituitary resistance to thyroid hormone, generalized resistance to thyroid hormone, thyroid hormone resistance, generalized, autosomal dominant, glycogen storage disease due to glycogen branching enzyme deficiency, thyroid hormone resistance, generalized, autosomal recessive, hypothyroidism, metabolic dysfunction-associated steatotic liver disease, differentiated thyroid carcinoma, hyperthyroidism, thyroid hormone resistance syndrome, atrial fibrillation, resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta.
Protein structure and variant hotspots
- Protein features: 1 domains; 14 binding sites.
- Structural context: 431 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable THRB variants
Examples include T2I, T2P, P3L, N4D, N4K, N4S, S5G, S5T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- T2I (p.Thr2Ile), Ensembl rs2047978862, CADD 26.00, PolyPhen-2 0.97
- T2P (p.Thr2Pro), cosmic curated COSV10072
- P3L (p.Pro3Leu), rs760749837, NCI-TCGA Cosmic COSV6284, cosmic curated COSV62841, ExAC rs760749837, CADD 26.70, PolyPhen-2 0.98, Uncertain significance, Inborn genetic diseases
- N4D (p.Asn4Asp), TOPMed rs1360759569
- N4K (p.Asn4Lys), gnomAD rs1180804605, CADD 26.90, PolyPhen-2 0.93
- N4S (p.Asn4Ser), rs114070375, ClinGen CA2287488, ClinVar RCV001145165, ClinVar RCV002287474, CADD 24.80, PolyPhen-2 0.90, Conflicting interpretations, not provided; Thyroid hormone resistance, generalized, autosomal dominant; See c
- S5G (p.Ser5Gly), ExAC rs758700967, CADD 24.50, PolyPhen-2 0.03
- S5T (p.Ser5Thr), TOPMed rs1284265411, gnomAD rs1284265411, CADD 22.50, PolyPhen-2 0.00
- M6I (p.Met6Ile), gnomAD rs1452039785, CADD 23.60, PolyPhen-2 0.38
- T7I (p.Thr7Ile), rs750046403, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10072, ExAC rs750046403, CADD 29.70, PolyPhen-2 0.03, Variant assessed as somatic; moderate impact.
- E8* (p.Glu8Ter), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10072, Variant assessed as somatic; high impact.
- E8A (p.Glu8Ala), gnomAD rs2043178862, CADD 31.00, Uncertain significance, Inborn genetic diseases
- G10C (p.Gly10Cys), cosmic curated COSV10072
- G10D (p.Gly10Asp), TOPMed rs1377046710, gnomAD rs1377046710
- L11V (p.Leu11Val), rs2474276508, ClinGen CA351891216, ClinVar RCV003242244, Uncertain significance, Inborn genetic diseases
- T12A (p.Thr12Ala), cosmic curated COSV62836
- T12I (p.Thr12Ile), TOPMed rs889830373, gnomAD rs889830373
- T12R (p.Thr12Arg), TOPMed rs889830373, gnomAD rs889830373
- A13G (p.Ala13Gly), rs886044192, ClinGen CA10606464, NCI-TCGA Cosmic COSV1007, ClinVar RCV000388556, MetaLR 0.74, MetaSVM 0.18, Uncertain significance
- A13T (p.Ala13Thr), NCI-TCGA Cosmic COSV6284, cosmic curated COSV62842, Variant assessed as somatic; moderate impact.
- W14R (p.Trp14Arg), rs777353759, ClinGen CA2287458, ClinVar RCV001461833, ExAC rs777353759, CADD 25.00, PolyPhen-2 0.26, Likely benign, not provided
- D15E (p.Asp15Glu), ExAC rs755700950, gnomAD rs755700950
- D15H (p.Asp15His), gnomAD rs1414721864, CADD 23.20, PolyPhen-2 0.00
- D15Y (p.Asp15Tyr), gnomAD rs1414721864, CADD 23.40, PolyPhen-2 0.06
- P17A (p.Pro17Ala), ExAC rs752640335, CADD 19.40, PolyPhen-2 0.02
- P17L (p.Pro17Leu), ExAC rs767393658, TOPMed rs767393658, gnomAD rs767393658, CADD 22.40, PolyPhen-2 0.00
- P17S (p.Pro17Ser), ExAC rs752640335, CADD 19.40, PolyPhen-2 0.03
- P17T (p.Pro17Thr), ExAC rs752640335, CADD 20.40, PolyPhen-2 0.05
- K18Q (p.Lys18Gln), rs141960389, ClinGen CA2287452, ClinVar RCV000591894, 1000Genomes rs141960389, CADD 23.50, PolyPhen-2 0.07, Uncertain significance, not provided
- H19Q (p.His19Gln), cosmic curated COSV62841
- H19R (p.His19Arg), ExAC rs751368272, gnomAD rs751368272, CADD 7.67, PolyPhen-2 0.00
- C20R (p.Cys20Arg), Ensembl rs2043173451, CADD 18.60, PolyPhen-2 0.01
- C20Y (p.Cys20Tyr), ExAC rs765488277, gnomAD rs765488277, CADD 19.20, PolyPhen-2 0.01
- P21A (p.Pro21Ala), ExAC rs761953487, gnomAD rs761953487, CADD 19.30, PolyPhen-2 0.00
- D22G (p.Asp22Gly), gnomAD rs1442088068, CADD 21.70, PolyPhen-2 0.01
- D22H (p.Asp22His), TOPMed rs1237891687, gnomAD rs1237891687, CADD 18.00, PolyPhen-2 0.00
- D22N (p.Asp22Asn), cosmic curated COSV62843
- R23* (p.Arg23Ter), rs886043743, ClinGen CA10605889, ClinVar RCV000269235, TOPMed rs886043743, CADD 34.00, Pathogenic
- R23Q (p.Arg23Gln), rs200124942, ClinGen CA2287448, ClinVar RCV001145164, ClinVar RCV005437002, CADD 17.20, PolyPhen-2 0.00, Likely benign, not specified; Thyroid hormone resistance, generalized, autosomal dominant
- E24Q (p.Glu24Gln), cosmic curated COSV62842
- H25Q (p.His25Gln), ExAC rs760778175, TOPMed rs760778175, gnomAD rs760778175, CADD 14.60, PolyPhen-2 0.00, Likely benign
- D26H (p.Asp26His), ExAC rs776036533, gnomAD rs776036533, CADD 22.60
- D26N (p.Asp26Asn), rs776036533, NCI-TCGA Cosmic COSV6283, cosmic curated COSV62833, ExAC rs776036533, CADD 18.50, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- W27* (p.Trp27Ter), TOPMed rs1212890194, CADD 37.00
- W27G (p.Trp27Gly), TOPMed rs1345675367
- W27S (p.Trp27Ser), cosmic curated COSV62839
- K28R (p.Lys28Arg), gnomAD rs1381754438, CADD 22.40, PolyPhen-2 0.01
- G31A (p.Gly31Ala), TOPMed rs2043167505
- M32K (p.Met32Lys), TOPMed rs1436959402
- M32V (p.Met32Val), ExAC rs746230410, gnomAD rs746230410
- S33P (p.Ser33Pro), NCI-TCGA Cosmic COSV6284, cosmic curated COSV62842, Variant assessed as somatic; moderate impact.
- S33T (p.Ser33Thr), 1000Genomes rs116576135, ExAC rs116576135, gnomAD rs116576135, CADD 19.70, PolyPhen-2 0.00
- E34K (p.Glu34Lys), ExAC rs771428244, gnomAD rs771428244, CADD 22.60, PolyPhen-2 0.00
- A35V (p.Ala35Val), gnomAD rs1420972928, CADD 19.30, PolyPhen-2 0.01
- C36Y (p.Cys36Tyr), ExAC rs758677446, TOPMed rs758677446, gnomAD rs758677446, CADD 22.70, PolyPhen-2 0.00, Uncertain significance, not provided
- L37P (p.Leu37Pro), TOPMed rs1157945635, gnomAD rs1157945635, CADD 24.30, PolyPhen-2 0.33
- H38P (p.His38Pro), ExAC rs755653928, TOPMed rs755653928, gnomAD rs755653928, CADD 19.90, PolyPhen-2 0.00
- H38R (p.His38Arg), ExAC rs755653928, TOPMed rs755653928, gnomAD rs755653928, CADD 18.50, PolyPhen-2 0.00
- R39G (p.Arg39Gly), TOPMed rs879549499, gnomAD rs879549499, CADD 23.60, PolyPhen-2 0.03
- R39K (p.Arg39Lys), cosmic curated COSV10466, CADD 19.90, PolyPhen-2 0.00
- K40R (p.Lys40Arg), cosmic curated COSV62834
- S41N (p.Ser41Asn), gnomAD rs1472555809, CADD 19.50, PolyPhen-2 0.01
- H42N (p.His42Asn), gnomAD rs1235937444, CADD 22.80, PolyPhen-2 0.03
- S43L (p.Ser43Leu), cosmic curated COSV11521
- S43P (p.Ser43Pro), TOPMed rs2043163509
- R45K (p.Arg45Lys), TOPMed rs1159347290
- R46C (p.Arg46Cys), rs754933969, NCI-TCGA Cosmic COSV6283, cosmic curated COSV62835, ExAC rs754933969, CADD 22.80, PolyPhen-2 0.06, Uncertain significance, Inborn genetic diseases
- R46G (p.Arg46Gly), ExAC rs754933969, gnomAD rs754933969, CADD 18.90, PolyPhen-2 0.00
- R46H (p.Arg46His), rs556429294, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10072, 1000Genomes rs556429294, CADD 17.50, PolyPhen-2 0.00, Likely benign, Thyroid hormone resistance, generalized, autosomal recessive
- R46L (p.Arg46Leu), 1000Genomes rs556429294, ExAC rs556429294, TOPMed rs556429294, gnomAD rs556429294, CADD 17.20, PolyPhen-2 0.01
- S47G (p.Ser47Gly), 1000Genomes rs538327722, ExAC rs538327722, TOPMed rs538327722, gnomAD rs538327722, CADD 6.96, PolyPhen-2 0.00
- T48M (p.Thr48Met), rs758209560, NCI-TCGA Cosmic COSV6283, cosmic curated COSV62838, ExAC rs758209560, CADD 18.90, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- L49F (p.Leu49Phe), ESP rs367747228, CADD 17.60, PolyPhen-2 0.35
- L49M (p.Leu49Met), ExAC rs764343535, gnomAD rs764343535, CADD 4.08, PolyPhen-2 0.35
- K50* (p.Lys50Ter), cosmic curated COSV62836
- K50I (p.Lys50Ile), TOPMed rs1337139174, gnomAD rs1337139174, CADD 22.70
- K50Q (p.Lys50Gln), ESP rs374885395, ExAC rs374885395, TOPMed rs374885395, gnomAD rs374885395, CADD 22.10, PolyPhen-2 0.04, Uncertain significance, Thyroid hormone resistance, generalized, autosomal dominant; Thyroid hormone res
- E52G (p.Glu52Gly), rs775495128, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10072, ExAC rs775495128, CADD 19.60, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- E52K (p.Glu52Lys), cosmic curated COSV62834
- Q53H (p.Gln53His), rs567722846, ClinGen CA2287427, ClinVar RCV001406958, ClinVar RCV005749827, CADD 19.60, Conflicting interpretations, not provided; Inborn genetic diseases
- Q53R (p.Gln53Arg), gnomAD rs1360563345, CADD 22.00
- S54L (p.Ser54Leu), rs141731067, ClinGen CA2287426, cosmic curated COSV62843, ClinVar RCV001403729, CADD 21.80, PolyPhen-2 0.01, Conflicting interpretations, Inborn genetic diseases; not provided
- S55L (p.Ser55Leu), rs926854046, NCI-TCGA Cosmic COSV6283, cosmic curated COSV62836, TOPMed rs926854046, CADD 15.20, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- P56L (p.Pro56Leu), NCI-TCGA Cosmic COSV6284, cosmic curated COSV62842, CADD 21.60, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- H57L (p.His57Leu), TOPMed rs1415456382, gnomAD rs1415456382, CADD 21.40, PolyPhen-2 0.01
- H57Q (p.His57Gln), rs749708494, ClinGen CA2287423, ClinVar RCV002945306, ExAC rs749708494, CADD 8.52, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- H57R (p.His57Arg), TOPMed rs1415456382, gnomAD rs1415456382, CADD 19.90, PolyPhen-2 0.00
- H57Y (p.His57Tyr), NCI-TCGA Cosmic COSV6283, cosmic curated COSV62839, Variant assessed as somatic; moderate impact.
- L58F (p.Leu58Phe), cosmic curated COSV62841, CADD 23.10, PolyPhen-2 0.00
- L58I (p.Leu58Ile), rs772976219, ClinGen CA2287422, ClinVar RCV002945300, ExAC rs772976219, CADD 22.90, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases
- I59F (p.Ile59Phe), 1000Genomes rs141172732, ESP rs141172732, ExAC rs141172732, TOPMed rs141172732, CADD 21.00, PolyPhen-2 0.01, Benign
- I59L (p.Ile59Leu), cosmic curated COSV62836, CADD 16.20, PolyPhen-2 0.00
- I59V (p.Ile59Val), rs141172732, ClinGen CA2287421, ClinVar RCV000896879, ClinVar RCV002487963, CADD 18.10, PolyPhen-2 0.00, Benign/Likely benign, not provided; Thyroid hormone resistance, generalized, autosomal recessive; Sele
- Q60K (p.Gln60Lys), ExAC rs747689098, gnomAD rs747689098, CADD 22.90, PolyPhen-2 0.00
- T61N (p.Thr61Asn), rs886058292, ClinGen CA10618010, ClinVar RCV000281467, Ensembl rs886058292, CADD 22.50, PolyPhen-2 0.00, Uncertain significance, Thyroid hormone resistance, generalized, autosomal dominant
- T62P (p.Thr62Pro), ExAC rs754525522, gnomAD rs754525522
- T62S (p.Thr62Ser), TOPMed rs1252462458, CADD 20.70
- W63C (p.Trp63Cys), ExAC rs780068828, gnomAD rs780068828, CADD 25.00, PolyPhen-2 0.00
- W63S (p.Trp63Ser), cosmic curated COSV10649
- S65G (p.Ser65Gly), gnomAD rs1260430863, CADD 23.30, PolyPhen-2 0.02
- S65R (p.Ser65Arg), TOPMed rs2043152808, CADD 23.10, PolyPhen-2 0.05
- S65T (p.Ser65Thr), ExAC rs758160589, TOPMed rs758160589, gnomAD rs758160589, CADD 21.80, PolyPhen-2 0.02, Uncertain significance, Inborn genetic diseases
- S66A (p.Ser66Ala), ExAC rs750270307, TOPMed rs750270307, gnomAD rs750270307, CADD 21.70, PolyPhen-2 0.01
- I67L (p.Ile67Leu), 1000Genomes rs147795893, ESP rs147795893, ExAC rs147795893, TOPMed rs147795893, Uncertain significance
- I67V (p.Ile67Val), rs147795893, ClinGen CA2287413, ClinVar RCV003901856, 1000Genomes rs147795893, CADD 9.68, PolyPhen-2 0.00, Uncertain significance, THRB-related disorder
- F68L (p.Phe68Leu), gnomAD rs1369173973, CADD 18.70, PolyPhen-2 0.01
- H69P (p.His69Pro), ExAC rs752968507, TOPMed rs752968507, gnomAD rs752968507
- H69R (p.His69Arg), ExAC rs752968507, TOPMed rs752968507, gnomAD rs752968507, CADD 20.80, PolyPhen-2 0.01
- H69Y (p.His69Tyr), rs756399184, NCI-TCGA Cosmic COSV6284, cosmic curated COSV62841, ExAC rs756399184, CADD 23.30, PolyPhen-2 0.05, Variant assessed as somatic; moderate impact.
- L70P (p.Leu70Pro), TOPMed rs1008025497, gnomAD rs1008025497, CADD 22.80
- D71E (p.Asp71Glu), rs141495471, ClinGen CA2287410, ClinVar RCV000375892, ClinVar RCV001800658, CADD 19.70, PolyPhen-2 0.02, Conflicting interpretations, THRB-related disorder; not provided; Thyroid hormone resistance, generalized, au
- D71H (p.Asp71His), TOPMed rs1166540831
- H72R (p.His72Arg), ExAC rs759685876, gnomAD rs759685876, CADD 16.20, PolyPhen-2 0.01
- D73E (p.Asp73Glu), TOPMed rs780345379, gnomAD rs780345379, CADD 0.33, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- D73Y (p.Asp73Tyr), TOPMed rs2043148990, CADD 20.60, PolyPhen-2 0.04
- D74N (p.Asp74Asn), ExAC rs767041112, gnomAD rs767041112, CADD 23.30, PolyPhen-2 0.04
- D74Y (p.Asp74Tyr), ExAC rs767041112, gnomAD rs767041112, CADD 23.30, PolyPhen-2 0.26
- D77N (p.Asp77Asn), rs549469339, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10072, 1000Genomes rs549469339, CADD 23.10, PolyPhen-2 0.03, Variant assessed as somatic; moderate impact.
- Q78H (p.Gln78His), gnomAD rs1388308378
- Q78R (p.Gln78Arg), gnomAD rs1295591047, CADD 17.80
- S79G (p.Ser79Gly), Ensembl rs933999524, CADD 19.00, PolyPhen-2 0.00
- S79R (p.Ser79Arg), Ensembl rs2149592821
- S79T (p.Ser79Thr), TOPMed rs1387972369, gnomAD rs1387972369, CADD 16.40
- V80A (p.Val80Ala), cosmic curated COSV10072
- V80D (p.Val80Asp), gnomAD rs2043146218, CADD 22.00, PolyPhen-2 0.07
- S81L (p.Ser81Leu), TOPMed rs1301951155, CADD 19.90, PolyPhen-2 0.00
- A83V (p.Ala83Val), ESP rs367980200, TOPMed rs367980200, gnomAD rs367980200, CADD 23.00, PolyPhen-2 0.03
- Q84H (p.Gln84His), rs1318258001, TOPMed rs1318258001, AlphaMissense 0.09, MetaLR 0.73, Variant assessed as somatic; moderate impact.
- T85S (p.Thr85Ser), rs61756233, ClinGen CA2287403, ClinVar RCV003292075, ExAC rs61756233, CADD 12.90, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases
- Q87H (p.Gln87His), ESP rs143576635, TOPMed rs143576635, gnomAD rs143576635, CADD 16.60, PolyPhen-2 0.00
- T88M (p.Thr88Met), ESP rs375817357, ExAC rs375817357, TOPMed rs375817357, gnomAD rs375817357, CADD 18.00, PolyPhen-2 0.03
- E89V (p.Glu89Val), TOPMed rs1268088648, CADD 24.30, PolyPhen-2 0.14
- E90D (p.Glu90Asp), cosmic curated COSV10968, ExAC rs746571600, gnomAD rs746571600
- E90K (p.Glu90Lys), TOPMed rs1428476390, CADD 22.30, PolyPhen-2 0.04
- K91N (p.Lys91Asn), TOPMed rs1559551773, CADD 23.40, PolyPhen-2 0.06
- K92R (p.Lys92Arg), rs2474261511, ClinGen CA351890467, ClinVar RCV002893168, Uncertain significance, Inborn genetic diseases
- C93G (p.Cys93Gly), Ensembl rs926195655
- C93Y (p.Cys93Tyr), TOPMed rs1191585380, CADD 20.20, PolyPhen-2 0.00
- K94Q (p.Lys94Gln), cosmic curated COSV10072
- G95E (p.Gly95Glu), cosmic curated COSV10880, NCI-TCGA TCGA novel, CADD 28.90, PolyPhen-2 0.93, Variant assessed as somatic; moderate impact.
- I97N (p.Ile97Asn), ExAC rs756851325, gnomAD rs756851325, CADD 28.90, PolyPhen-2 0.73
- I97V (p.Ile97Val), ExAC rs778510901, gnomAD rs778510901, CADD 21.60, PolyPhen-2 0.01
- Y100C (p.Tyr100Cys), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- E105K (p.Glu105Lys), Ensembl rs2149104148, CADD 28.90, PolyPhen-2 1.00
- L106I (p.Leu106Ile), Ensembl rs868009596, CADD 20.60, PolyPhen-2 0.12
- L106P (p.Leu106Pro), TOPMed rs1254993640, gnomAD rs1254993640, CADD 23.00, PolyPhen-2 0.05
- G111C (p.Gly111Cys), cosmic curated COSV54980
- G111S (p.Gly111Ser), gnomAD rs1185248813, CADD 23.50, PolyPhen-2 0.21
- A114G (p.Ala114Gly), cosmic curated COSV54980
- G116R (p.Gly116Arg), rs1467459460, TOPMed rs1467459460, gnomAD rs1467459460, CADD 27.50, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- G116V (p.Gly116Val), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- Y117C (p.Tyr117Cys), TOPMed rs1270859327, gnomAD rs1270859327, CADD 29.40, PolyPhen-2 1.00
- Y117N (p.Tyr117Asn), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- H118P (p.His118Pro), Ensembl rs868418381
- R120C (p.Arg120Cys), ExAC rs752495674, gnomAD rs752495674, CADD 32.00, PolyPhen-2 1.00
- R120H (p.Arg120His), ExAC rs766622559, TOPMed rs766622559, gnomAD rs766622559, CADD 25.10, PolyPhen-2 1.00
- I122V (p.Ile122Val), rs2149103720, ClinGen CA351885954, cosmic curated COSV54981, ClinVar RCV001532477, AlphaMissense 0.80, MetaLR 0.90, Uncertain significance, not provided
- T123M (p.Thr123Met), cosmic curated COSV54980, ExAC rs763024316, gnomAD rs763024316, CADD 29.60, PolyPhen-2 1.00
- E125K (p.Glu125Lys), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- G126C (p.Gly126Cys), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- K128R (p.Lys128Arg), cosmic curated COSV11369
- G129V (p.Gly129Val), cosmic curated COSV10881
- G129C (p.Gly129Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G129G (p.Gly129Gly), gnomAD 3-24146820-A-T, CADD 13.00
- F131L (p.Phe131Leu), Ensembl rs1559450768
- F131V (p.Phe131Val), cosmic curated COSV10956
- F131C (p.Phe131Cys), gnomAD 3-24146815-A-C, CADD 29.20, PolyPhen-2 1.00
- R132K (p.Arg132Lys), NCI-TCGA Cosmic COSV9976, cosmic curated COSV99769, Variant assessed as somatic; moderate impact.
- R132R (p.Arg132Arg), rs767165069, gnomAD 3-24146811-T-C, CADD 14.40
- R133del (p.Arg133del), gnomAD 3-24146806-GTTC-G, CADD 22.70
- T134I (p.Thr134Ile), cosmic curated COSV54980
- T134T (p.Thr134Thr), gnomAD 3-24146805-G-T, CADD 10.30
- K137R (p.Lys137Arg), ExAC rs754829672, gnomAD rs754829672, CADD 27.40, PolyPhen-2 1.00
- N138N (p.Asn138Asn), gnomAD 3-24146793-A-G, CADD 10.30
- N138S (p.Asn138Ser), gnomAD 3-24146794-T-C, CADD 21.60, PolyPhen-2 0.08
- L139I (p.Leu139Ile), rs1467626353, cosmic curated COSV10460, gnomAD rs1467626353, CADD 27.30, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- L139del (p.Leu139del), gnomAD 3-24146788-TGGA-T, CADD 21.00
- L139L (p.Leu139Leu), rs750609052, gnomAD 3-24146790-G-C, CADD 9.13
- H140Q (p.His140Gln), gnomAD 3-24146787-A-T, CADD 22.80, PolyPhen-2 0.84
- P141A (p.Pro141Ala), cosmic curated COSV54980
Public THRB analysis runs
- THRB analysis run — THRB (756 variants) — completed 2026-09-08